Orion Group Holdings, Inc.
NYSE:ORNEngineering & Construction
+$0.48 today
- Market cap
- $300.07M
- Beta
- 1.38
- P/E (TTM)
- 73.6
- EPS (TTM)
- $0.21
Volume 0.92M
Average 0.34M
ORN Net Income
Bottom-line profit, the starting point for calculating cash from operations.
Orion Group Holdings, Inc.NYSE: ORN
Net Income · Q1 FY2026 · quarter ended Mar 2026
Net income turns positive
Q1 FY2026 net income was $4.69M, compared with -$1.41M a year earlier. Trailing-twelve-month net income was $9.43M.
Context
- Net income amounted to 0.3% of revenue in FY2025, unchanged from a year earlier.
- Net income increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether net income reaches the consensus estimate from 5 analysts of $9.79M (+293.4%) for the fiscal year ending Dec 2026, a step up from the +251.3% reported in FY2025.
Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- $4.69M+679.9% QoQ
- Last fiscal yearDec 2025
- $2.49M+251.3% YoY
- LTMMar 2026
- $9.43M+214.4% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +431.5% | +201.0% | -230.4 pp |
| 1 year | +251.3% | +293.4% | +42.0 pp |
| 3-year CAGR | — | +126.2% | — |
| 5-year CAGR | +76.0% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Income history
USD · from the cash flow
- Latest · FY2025
- 2.49M USD
- Year-over-year change
- +251.3%
| Period | Period end | Net Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 2.49M | +251.3% |
| FY2024 | 2024-12-31 | (1.64M) | +90.8% |
| FY2023 | 2023-12-31 | (17.88M) | -41.7% |
| FY2022 | 2022-12-31 | (12.61M) | +13.4% |
| FY2021 | 2021-12-31 | (14.56M) | — |
Net Income vs competitors
How ORN compares with its peers on the latest reported figures
- Peers report in different currencies, so net income is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +214.4% is the highest of 10, against a peer median of -25.4%.
- Net income amounts to 1.1% of revenue for ORN, versus a peer median of 7.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | £237.85M GBP | — | — | — | |
| LTM Apr 2026 | $152.56M USD | -282.8% | — | 9.9% | |
| LTM Feb 2026 | $42.63M USD | +6.0% | -3.4% | 10.9% | |
| LTM Mar 2026 | $26.47M USD | -3.3% | — | 142.6% | |
SRTAStrata Critical Medical, Inc. | LTM Mar 2026 | $19.83M USD | -25.4% | — | 7.8% |
| LTM Apr 2026 | $18.48M USD | +37.7% | -20.6% | 3.5% | |
| LTM Mar 2026 | $14.99M USD | -33.6% | -22.7% | 1.8% | |
| LTM Mar 2026 | $11.27M USD | +91.6% | +1.7% | 15.4% | |
| LTM Mar 2026 | $9.43M USD | +214.4% | — | 1.1% | |
| LTM Apr 2026 | $9.12M USD | -36.4% | -39.4% | 2.2% | |
| LTM Feb 2026 | $8.83M USD | -38.9% | — | 7.3% | |
| Peer median (excluding ORN) | — | -25.4% | -20.6% | 7.8% | |
Competitors are the stored peer set for ORN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (14.56M) | (12.61M) | (17.88M) | (1.64M) | 2.49M |
| Depreciation & Amortization | 30.53M | 28.87M | 30.64M | 32.73M | 21.94M |
| Deferred Income Tax | (9K) | 13K | (103K) | (27K) | 52K |
| Stock-Based Compensation | 2.4M | 2.75M | 2.04M | 4.01M | 5.45M |
| Change in Working Capital | (8.1M) | (5.24M) | 2.41M | (21.7M) | (8.56M) |
| Accounts Receivables | 8.46M | (44.03M) | (23.71M) | (850K) | (32.76M) |
| Inventory | 371K | (1.49M) | (729K) | (554K) | 787K |
| Accounts Payables | 589K | 39.37M | (4.51M) | 16.02M | 11.09M |
| Other Working Capital | (17.52M) | 910K | 31.36M | (36.31M) | 12.33M |
| Other Non-Cash Items | (10.2M) | (4.22M) | 61K | (689K) | 6.7M |
| Operating Cash Flow | 69K | 9.57M | 17.18M | 12.68M | 28.07M |
| Capital Expenditures | (16.98M) | (14.58M) | (8.91M) | (14.09M) | (38.86M) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 27.6M | 4.88M | 11.08M | 2.61M | 25.16M |
| Investing Cash Flow | 10.63M | (9.7M) | 2.17M | (11.48M) | (13.7M) |
| Debt Repayment | 845K | (7.27M) | 14.84M | (30.26M) | (42.32M) |
| Common Stock Issued | 0 | 0 | 0 | 26.42M | 0 |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (839K) | (1.1M) | (7.03M) | 25K | 2.93M |
| Financing Cash Flow | 6K | (8.37M) | 7.81M | (3.82M) | (39.39M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 10.7M | (8.51M) | 27.15M | (2.62M) | (25.03M) |
| Free Cash Flow | (16.91M) | (5.02M) | 8.27M | (1.42M) | (10.8M) |
Orion Group Holdings, Inc.
NYSE:ORN
Intrinsic Alpha fair value
Locked
Current Price
$7.38
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.